Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)
Author(s):
Ossenkoppele, G.J.; Stussi, G.; Maertens, J.; Montfort, K. van; Biemond, B.J.; Breems, D.; Ferrant, A.; Graux, C.; Greef, G.E. de; Halkes, C.J.M.; Hoogendoorn, M.; Hollestein, R.M.; Jongen-Lavrencic, M.; Levin, M.D.; Loosdrecht, A.A. van de; Kooij, M.V.; Norden, Y. van; Pabst, T.; Schouten, H.C.; Vellenga, E.; Verhoef, G.E.G.; Weerdt, O. de; Wijermans, P.; Passweg, J.R.; Lowenberg, B.
